Details van artikel 243 van 359 gevonden artikelen
Prevalence of KRAS, NRAS and BRAF mutations detected by massive parallel sequencing and differential clinical outcome in metastatic colorectal cancer (MCRC) patients (pts) treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy
Titel:
Prevalence of KRAS, NRAS and BRAF mutations detected by massive parallel sequencing and differential clinical outcome in metastatic colorectal cancer (MCRC) patients (pts) treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy
Auteur:
Bruera, G. Pepe, F. Malapelle, U. Pisapia, P. Dal Mas, A. Di Giacomo, D. Calvisi, G. Troncone, G. Ricevuto, E.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 28 () nr. S6 pagina's vi14
Jaar:
2017
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 243 van 359 gevonden artikelen